Bioventus Valuation
| BVS Stock | USD 9.80 0.19 1.98% |
At this time, the firm appears to be undervalued. Bioventus shows a prevailing Real Value of $12.43 per share. The current price of the firm is $9.8. Our model approximates the value of Bioventus from analyzing the firm fundamentals such as Return On Equity of -0.22, current valuation of 930.47 M, and Profit Margin of (0.06) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bioventus' valuation include:
Price Book 4.3019 | Enterprise Value | Enterprise Value Ebitda 23.7239 | Price Sales 1.109 | Forward PE 16.3132 |
Undervalued
Today
Please note that Bioventus' price fluctuation is somewhat reliable at this time. Calculation of the real value of Bioventus is based on 3 months time horizon. Increasing Bioventus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioventus stock is determined by what a typical buyer is willing to pay for full or partial control of Bioventus. Since Bioventus is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioventus Stock. However, Bioventus' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.8 | Real 12.43 | Target 15.0 | Hype 9.74 |
The intrinsic value of Bioventus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioventus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bioventus helps investors to forecast how Bioventus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioventus more accurately as focusing exclusively on Bioventus' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bioventus' intrinsic value based on its ongoing forecasts of Bioventus' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bioventus' closest peers.
Bioventus Cash |
|
Bioventus Valuation Trend
Bioventus' real value is important for investors to make better decisions and a more accurate overall view of Bioventus' financial worth over time. Using both Bioventus' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Bioventus Revenue by Product
Bioventus Total Value Analysis
Bioventus is currently anticipated to have company total value of 930.47 M with market capitalization of 635.77 M, debt of 27.34 M, and cash on hands of 34.36 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Bioventus fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
930.47 M | 635.77 M | 27.34 M | 34.36 M |
Bioventus Investor Information
About 70.0% of the company shares are held by institutions such as insurance companies. The book value of Bioventus was currently reported as 2.25. The company has Price/Earnings To Growth (PEG) ratio of 2.14. Bioventus recorded a loss per share of 0.52. The entity had not issued any dividends in recent years. Based on the key indicators related to Bioventus' liquidity, profitability, solvency, and operating efficiency, Bioventus may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Bioventus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioventus has an asset utilization ratio of 78.75 percent. This implies that the Company is making $0.79 for each dollar of assets. An increasing asset utilization means that Bioventus is more efficient with each dollar of assets it utilizes for everyday operations.Bioventus Ownership Allocation
Bioventus holds a total of 66.16 Million outstanding shares. Over half of Bioventus' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioventus Profitability Analysis
The company reported the last year's revenue of 573.28 M. Reported Net Loss for the year was (33.54 M) with profit before taxes, overhead, and interest of 388.23 M.About Bioventus Valuation
The stock valuation mechanism determines Bioventus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bioventus based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioventus. We calculate exposure to Bioventus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioventus's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 573.3 M | 303.8 M | |
| Pretax Profit Margin | (0.09) | (0.09) | |
| Operating Profit Margin | (0.16) | (0.14) | |
| Net Loss | (0.09) | (0.09) | |
| Gross Profit Margin | 0.74 | 0.76 |
Bioventus Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bioventus does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 65.4 M | |
| Forward Price Earnings | 16.3132 |
Bioventus Current Valuation Indicators
Bioventus' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Bioventus' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bioventus, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bioventus' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bioventus' worth.Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.